APGE STOCK ANALYSIS
Price summary
Last Close
132.91 $
Jul 2, 26
Market Cap
9.3 B $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+199.9
Volatility
%74.4
Sharpe Ratio
1.28
Sortino Ratio
1.93
Distance to Peak
%0.0
Maximum Drawdown
-%27.0
Seasonality
Seasonality Chart
Periodic Returns
1M
+68.9%
3M
+57.6%
6M
+76.1%
YTD
+76.1%
1Y
+199.9%
3Y
—
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current Apogee Therapeutics, Inc. Common Stock (APGE) stock price?
APGE last closed at 132.91 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the market capitalization of Apogee Therapeutics, Inc. Common Stock?
Apogee Therapeutics, Inc. Common Stock (APGE) has a market capitalization of approximately 9.3 B $ as of the latest reported period.
Who are the main competitors of APGE?
Key peers of Apogee Therapeutics, Inc. Common Stock include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.
Go deeper on APGE
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
